Association of Triglyceride-Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study

Affiliations

Ahmed Bashir et al. J Clin Hypertens (Greenwich). 2025 Sep.

. 2025 Sep;27(9):e70158.

doi: 10.1111/jch.70158.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. Huang X., Ye J., Liu S., et al., “Association of Triglyceride‐Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study,” Journal of Clinical Hypertension 27, no. 8 (2025): e70114, 10.1111/jch.70114. - DOI - PMC - PubMed
1. Tao L. C., Xu J. N., Wang T. T., Hua F., and Li J. J., “Triglyceride‐Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations,” Cardiovascular Diabetology 21, no. 1 (2022): 68, 10.1186/s12933-022-01511-x. - DOI - PMC - PubMed
1. Sánchez‐García A., Rodríguez‐Gutiérrez R., Mancillas‐Adame L., et al., “Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review,” International Journal of Endocrinology (2020): 4678526, 10.1155/2020/4678526. - DOI - PMC - PubMed
1. Ji W., Gao L., Sun P., et al., “Association of the Triglyceride‐Glucose Index and Vascular Target Organ Damage in a Beijing Community‐Based Population,” Frontiers in Cardiovascular Medicine 9 (2022): 948402, 10.3389/fcvm.2022.948402. - DOI - PMC - PubMed
1. Liu S., Zhang H., Wu M., et al., “Association Between the Triglyceride‐Glucose Index and Carotid Artery Plaque Burden in Patients With Primary Hypertension: A Cross‐Sectional Study,” Clinical and Experimental Hypertension 46, no. 1 (2024): 2383232, 10.1080/10641963.2024.2383232. Epub 2024 Jul 24. - DOI - PubMed